Skip to main content

Table 2 Basic information of the 14 GEO datasets

From: PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression

Cancer type Accession number Number of samples (tumor/normal) P-value References
Upregulated
Hepatocellular carcinoma GSE14520 233/233 < 0.0001 [57, 58]
Breast carcinoma GSE10780 42/143 0.0002 [59]
Gastric cancer GSE13861 71/19 0.0388 [60]
Ovarian cancer GSE14407 12/12 0.0438 [61]
Downregulated
Pancreatic cancer GSE28735 45/45 0.0003 [62, 63]
Colorectal cancer GSE32323 17/17 0.0011 [64]
Insignificant
Melanoma GSE3189 45/7 0.0848 [65]
Bladder cancer GSE3167 41/9 0.1243 [66]
Acute lymphoblastic leukemia GSE26713 117/7 0.2168 [67]
Renal clear cell carcinoma GSE36895 23/23 0.2445 [68]
Esophageal carcinoma GSE23400 53/53 0.2526 [69, 70]
Nasopharyngeal carcinoma GSE12452 31/10 0.2710 [71,72,73]
Lung cancer GSE30219 293/14 0.2938 [74]
Prostate cancer GSE6919 58/58 0.7478 [75, 76]
  1. P-values were acquired through t-test for the comparison of PEG10 expression between cancer and normal